$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq Announces End of Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 28, 2024
04:05pm, Wednesday, 10'th Jul 2024
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 28, 2024, short interest in 3,052 Nasdaq Global MarketSM securities totaled 12,156,830,526 shares compared with 12
Nasdaq Gains 1%; LegalZoom Shares Slide
02:31pm, Wednesday, 10'th Jul 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Wednesday.
Nasdaq Surges 100 Points; Manchester United Shares Rise After Q3 Results
10:16am, Wednesday, 10'th Jul 2024
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.
Nasdaq Index, Dow Jones, S&P 500 News: TSMC Surges On Strong Q2 Results, Boosting Tech Sector
09:02am, Wednesday, 10'th Jul 2024
Nasdaq 100 climbs on bullish tech sentiment. TSMC gains 2% after strong earnings, Tesla up 1% on analyst upgrade, driving index higher.
WARREN, N.J., July 10, 2024 (GLOBE NEWSWIRE) -- Dr. Neal Flomenberg and Dr. Lori Grosso of Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty imm
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Wednesday, 10'th Jul 2024
EMERYVILLE, Calif., July 10, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 09'th Jul 2024
LEXINGTON, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agr
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 09'th Jul 2024
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of July 1, 2024, the Compensation Co
Final Trades: Nasdaq, Energy Transfer, Hilton Worldwide and Ventas
01:30pm, Tuesday, 09'th Jul 2024
The Investment Committee give you their top stocks to watch.
Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
12:13pm, Tuesday, 09'th Jul 2024
CAMBRIDGE, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large mark
Nasdaq 100, Dow Jones, S&P 500 News: Powell, NVIDIA Fuel Rally as Market Hits Record Highs
10:48am, Tuesday, 09'th Jul 2024
S&P 500 and Nasdaq maintain bullish trend, fueled by AI-driven tech leaders like NVIDIA, despite concerns over market concentration and valuations.
NCI Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
07:20am, Tuesday, 09'th Jul 2024
HONG KONG, July 09, 2024 (GLOBE NEWSWIRE) -- Neo-Concept International Group Holdings Limited (Nasdaq: NCI) (the “Company”), announced that, on July 8, 2024, the Company received a letter from the
Nasdaq and S&P 500 notch record closes as Apple, Amazon, Meta hit record highs
05:48pm, Monday, 08'th Jul 2024
Ryan Detrick, Carson Group chief market strategist, and Nicole Webb, Wealth Enhancement Group SVP, join 'Closing Bell Overtime' to talk the day's record market action.
Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05:25pm, Monday, 08'th Jul 2024
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants $10 million upfront with up to an additional $20 million upon the exerci
Nasdaq Reports June 2024 Volumes and 2Q24 Statistics
04:05pm, Monday, 08'th Jul 2024
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for June 2024, as well as quarterly volumes, estimated revenue capture, number of listings, and index s
Sign In
Buy NDAQ